rs377022215
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_001040108.2(MLH3):c.3539G>A(p.Arg1180His) variant causes a missense change. The variant allele was found at a frequency of 0.0000942 in 1,571,810 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1180G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001040108.2 missense
Scores
Clinical Significance
Conservation
Publications
- colorectal cancer, hereditary nonpolyposis, type 7Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000416 AC: 6AN: 144368Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 31AN: 250732 AF XY: 0.0000885 show subpopulations
GnomAD4 exome AF: 0.0000995 AC: 142AN: 1427442Hom.: 0 Cov.: 27 AF XY: 0.0000942 AC XY: 67AN XY: 711234 show subpopulations
GnomAD4 genome AF: 0.0000416 AC: 6AN: 144368Hom.: 0 Cov.: 27 AF XY: 0.0000431 AC XY: 3AN XY: 69620 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:2
The p.R1180H variant (also known as c.3539G>A), located in coding exon 4 of the MLH3 gene, results from a G to A substitution at nucleotide position 3539. The arginine at codon 1180 is replaced by histidine, an amino acid with highly similar properties. This alteration was identified in the heterozygous state in a cohort of pancreatic cancer patients undergoing multigene panel testing (Young EL et al. BMC Cancer, 2018 Jun;18:697). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1180 of the MLH3 protein (p.Arg1180His). This variant is present in population databases (rs377022215, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 478037). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Colorectal cancer;C0476089:Endometrial carcinoma;C1858380:Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
- -
MLH3-related disorder Uncertain:1
The MLH3 c.3539G>A variant is predicted to result in the amino acid substitution p.Arg1180His. This variant has been reported in an individual with a personal history of pancreatic cancer (Supplemental Table 2, Young et al. 2018. PubMed ID: 29945567). This variant is reported in 0.017% of alleles in individuals of European (Non-Finnish) descent in gnomAD. In ClinVar, it has been reported as a variant of uncertain significance by multiple laboratories (https://www.ncbi.nlm.nih.gov/clinvar/variation/478037/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at